Home

Grabar La ciudad Autenticación nmd pharma thomas hilm Pastor Salida Aumentar

NMD Pharma
NMD Pharma

NMD Pharma A/S | LinkedIn
NMD Pharma A/S | LinkedIn

Katja Krustrup Pedersen - Research Scientist and Project Manager - NMD  Pharma | LinkedIn
Katja Krustrup Pedersen - Research Scientist and Project Manager - NMD Pharma | LinkedIn

NMD Pharma - Inkef capital
NMD Pharma - Inkef capital

NMD Pharma - Inkef capital
NMD Pharma - Inkef capital

NMD Pharma A/S | LinkedIn
NMD Pharma A/S | LinkedIn

NMD Pharma - PIR International
NMD Pharma - PIR International

HITTA ER ET A UN AMI TA ON HI HA UT ME AT THE
HITTA ER ET A UN AMI TA ON HI HA UT ME AT THE

NMD Pharma ApS Annual Report for 1 January - 31 December 2017
NMD Pharma ApS Annual Report for 1 January - 31 December 2017

Management team — NMD Pharma
Management team — NMD Pharma

Thomas Holm Pedersen - Chief Executive Officer, Associate professor of  Physiology and Biophysics in Aarhus, Arhus, Denmark | eMedEvents
Thomas Holm Pedersen - Chief Executive Officer, Associate professor of Physiology and Biophysics in Aarhus, Arhus, Denmark | eMedEvents

NMD Pharma - Inkef capital
NMD Pharma - Inkef capital

NMD Pharma raises €38M (~USD 47 Million) SERIES A Financing to Advance  Treatments of Neuromuscular Disorders
NMD Pharma raises €38M (~USD 47 Million) SERIES A Financing to Advance Treatments of Neuromuscular Disorders

Management team — NMD Pharma
Management team — NMD Pharma

NMD Pharma breder sig til nye områder før næste kapitalrejsning
NMD Pharma breder sig til nye områder før næste kapitalrejsning

Management team — NMD Pharma
Management team — NMD Pharma

NMD Pharma - PIR International
NMD Pharma - PIR International

Patient Dosing Begins in Early Trial of Oral NMD670 for Myasthenia Gravis
Patient Dosing Begins in Early Trial of Oral NMD670 for Myasthenia Gravis

NMD Pharma Information | NMD Pharma Profile
NMD Pharma Information | NMD Pharma Profile

PRESS RELEASE NMD Pharma Moves Corporate Headquarters to INCUBA to Support  Future Growth
PRESS RELEASE NMD Pharma Moves Corporate Headquarters to INCUBA to Support Future Growth

NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders

Thomas Holm Pedersen - Ownr.dk
Thomas Holm Pedersen - Ownr.dk

NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders

Management team — NMD Pharma
Management team — NMD Pharma

NMD Pharma Initiates Combined Phase I/II Clinical trial — NMD Pharma
NMD Pharma Initiates Combined Phase I/II Clinical trial — NMD Pharma

NMD Pharma A/S | LinkedIn
NMD Pharma A/S | LinkedIn